NYSE Euronext Announces Trading Volumes for September 2011 and Other Metrics

Double-Digit Growth in Trading Volumes Across All Venues Year-Over-Year

Global Derivatives ADV Up 23%; U.S. Equity Options ADV Up 32%

European Cash ADV Up 35%; U.S. Cash ADV Up 12%

NEW YORK--(BUSINESS WIRE)--NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for September 2011¹. Trading volumes across all venues were significantly higher year-over-year, but mostly declined sequentially from unseasonally strong levels in August 2011, which were driven by heightened market volatility in the U.S. and Europe. Global derivatives average daily volume (“ADV”) of 9.5 million contracts in September 2011 increased 23.2% versus the prior year, driven by a 32.1% increase in U.S. options ADV. Cash equities ADV in September 2011 was strong, with European cash trading ADV increasing 34.6% and U.S. cash trading ADV increasing 12.3% from September 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in September 2011 of 9.5 million contracts increased 23.2% compared to September 2010, but decreased 8.4% from elevated August 2011 levels.
• NYSE Euronext European derivatives products ADV in September 2011 of 4.8 million contracts increased 13.5% compared to September 2010 and increased 7.0% from August 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV increased 8.5% compared to September 2010 and decreased 8.5% from August 2011.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.6 million contracts in September 2011 increased 32.1% compared to September 2010 levels, but decreased 20.2% from August 2011. NYSE Euronext’s U.S. options exchanges accounted for 26.8% of total U.S. consolidated equity options trading in September 2011, up from 26.1% in September 2010 and up from 26.4% recorded in August 2011.
• NYSE Liffe U.S. ADV of approximately 113,400 contracts increased from 10,800 contracts in September 2010, but decreased from 137,100 contracts in August 2011.
• NYSE Euronext European cash products ADV of 1.9 million transactions in September 2011 increased 34.6% compared to September 2010, but decreased 13.5% from August 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.6 billion shares in September 2011 increased 12.3% compared to September 2010, but decreased 19.8% compared to August 2011. NYSE Euronext’s Tape A matched market share in September 2011 was 36.3%, down from 38.4% in September 2010, but up slightly from 36.2% in August 2011.
• There were a total of 22 trading days in Europe and 21 trading days in the U.S. in September 2011 compared to 22 trading days in Europe and 21 trading days in the U.S. in September 2010.
• The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the third quarter of 2011 is included below:

	2Q11 Actual	3Q11 Preliminary
European Derivatives (ex. Bclear)^1	$0.741	$0.69
U.S. Equity Options^2	$0.165	$0.15
European Cash^3	$0.742	$0.64
U.S. Cash^4	$0.039	$0.038
^1Average net revenue per contract, excluding Bclear.
^2Average net revenue per contract.
^3 Average net revenue per transaction.
^4 Average net revenue per 100 shares handled.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in September 2011 was 4.8 million futures and options contracts, an increase of 13.5% from September 2010 and an increase of 7.0% from August 2011.
• The 4.8 million in European derivatives futures and options contracts ADV in September 2011 consisted of 3.6 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.2 million contracts, or 24.5%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV increased 8.5% compared to September 2010 and decreased 8.5% from August 2011.
• In the third quarter of 2011, European derivatives products ADV of 4.3 million contracts was 13.6% above prior year levels. The 4.3 million in futures and options contracts ADV in the third quarter of 2011 consisted of 3.5 million contracts executed through LIFFE CONNECT trading platform and 0.8 million contracts, or 19.0%, executed through Bclear. Excluding Bclear, European derivatives products ADV in the third quarter of 2011 increased 18.1% compared to the prior year period.
• Year-to-date, European derivatives products ADV of 4.8 million contracts was 6.5% below prior year levels. The 4.8 million in futures and options contracts ADV year-to-date consisted of 3.5 million contracts executed through LIFFE CONNECT trading platform and 1.2 million contracts, or 25.9%, executed through Bclear.
• Total fixed income products ADV of 2.5 million contracts in September 2011 increased 14.2% from September 2010, but decreased 1.4% from August 2011. In the third quarter of 2011, total fixed income products ADV of 2.3 million contracts was 20.3% above prior year levels. Year-to-date, total fixed income products ADV of 2.4 million contracts was 1.5% below prior year levels.
• Total equity products (including Bclear) ADV of 2.2 million contracts in September 2011 increased 12.4% compared to September 2010 and increased 17.8% from August 2011. The 2.2 million contracts in equity products ADV consisted of 1.5 million contracts in individual equity products ADV and 0.7 million contracts in equity index products ADV. The 1.5 million contracts in individual equity products ADV consisted of 1.0 million in futures contracts, which represented a 37.4% increase compared to September 2010 and 0.5 million in options contracts, which represented a 16.1% decrease compared to September 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. In the third quarter of 2011, total equity products ADV of 1.9 million contracts was 7.1% above prior year levels. Year-to-date, total equity products ADV of 2.3 million contracts was 12.2% below prior year levels.
• Total commodities products ADV of 91,000 contracts in September 2011 increased 18.8% compared to September 2010 and increased 35.8% compared to August 2011. In the third quarter of 2011, total commodities product ADV of 78,700 contracts was 3.4% below prior year levels. Year-to-date, total commodities product ADV of 84,000 contracts was 32.3% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.6 million contracts in September 2011 increased 32.1% compared to September 2010, but decreased 20.2% compared to August 2011. In the third quarter of 2011, U.S. equity options ADV of 4.9 million contracts was 52.6% above prior year levels. Year-to-date, U.S. equity options ADV of 4.4 million contracts was 21.6% above prior year levels.
• Total U.S. consolidated equity options ADV increased 28.6% to 17.1 million contracts in September 2011 compared to September 2010, but decreased 21.5% compared to August 2011. In the third quarter of 2011, U.S. consolidated equity options ADV of 18.5 million contracts was 48.0% above prior year levels. Year-to-date, U.S. consolidated equity options ADV of 17.2 million contracts was 22.3% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 26.8% of the total U.S. consolidated equity options trading in September 2011, up from 26.1% in September 2010 and up from 26.4% in August 2011.
• NYSE Liffe U.S. ADV of approximately 113,400 contracts increased from 10,800 contracts in September 2010, but decreased from 137,100 contracts in August 2011. In the third quarter of 2011, U.S. futures and futures options ADV of 117,810 contracts compared to 10,700 contracts in the prior quarter. Year-to-date, U.S. futures and futures options ADV of 77,800 contracts was 368.6% above prior year levels.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.9 million transactions in September 2011 increased 34.6% compared to September 2010, but decreased 13.5% compared to August 2011.
• In the third quarter of 2011, European cash products ADV of 1.9 million transactions was 39.8% above prior year levels.
• Year-to-date, European cash products ADV of 1.8 million transactions was 18.2% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in September 2011 increased 12.3% to 2.6 billion shares compared to September 2010, but decreased 19.8% from August 2011.
• In the third quarter of 2011, U.S. cash products handled ADV was 2.6 billion shares, up 8.8% from prior year levels.
• Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 14.2% from prior year levels.
• NYSE Euronext’s Tape A matched market share in September 2011 was 36.3%, down from 38.4% in September 2010, but up slightly from 36.2% in August 2011.

Exchange Traded Funds

• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 421 million shares in September 2011 increased 39.7% compared to September 2010, but decreased 18.7% compared to August 2011.
• In the third quarter of 2011, NYSE Euronext U.S. matched exchange-traded funds ADV of 410 million shares was 31.1% above prior year levels.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 324 million shares was 7.9% below prior year levels.

Other Metrics

• On June 29, 2011, NYSE Euronext closed the sale of a 52.8% equity interest in the NYSE Amex Options exchange to seven leading order flow providers and market making firms including Bank of America Merrill Lynch, Barclays Capital, Citadel Securities, Citi, Goldman Sachs, TD Ameritrade and UBS AG. As a result of the sale, NYSE Euronext is now sharing the profits of NYSE Amex Options with our partners and in the third quarter, the profit attributable to the non-controlling interest related to NYSE Amex Options was $11 million.
• The average EUR/USD exchange rate for the third quarter of 2011 of $1.41 represented a decrease of 1.7% from the second quarter of 2011 and an increase of 9.4% compared to the third quarter of 2010.
• The average GBP/USD exchange rate for the third quarter of 2011 of $1.61 represented a decrease of 1.2% from the second quarter of 2011 and an increase of 3.9% compared to the third quarter of 2010.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. (“Holding”), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission (“SEC”) that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding’s offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) (“BaFin”), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC’s website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext’s website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding’s website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext
Monthly Volume Summary
	Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
								% Chg vs.		% Chg vs.
(Unaudited; contracts in thousands)	Sep-11	Sep-10	% Chg	Sep-11	Sep-10	% Chg	YTD 2011	YTD 2010	YTD 2011	YTD 2010
Number of Trading Days - European Markets	22	22		22	22		193		193
Number of Trading Days - U.S. Markets	21	21		21	21		189		189
European Derivatives Products	4,809	4,238	13.5%	105,799	93,235	13.5%	4,752	-6.5%	917,115	-6.0%
of which Bclear	1,179	893	32.0%	25,941	19,648	32.0%	1,232	-16.7%	237,718	-16.3%
Total Fixed Income Products	2,547	2,229	14.2%	56,029	49,048	14.2%	2,399	-1.5%	462,950	-1.0%
Short Term Interest Rate Products	2,400	2,110	13.8%	52,801	46,413	13.8%	2,258	-2.7%	435,804	-2.2%
Medium and Long Term Interest Rate Products^1	147	120	22.5%	3,228	2,635	22.5%	141	21.0%	27,146	21.6%
Total Equity Products^2	2,171	1,932	12.4%	47,760	42,494	12.4%	2,270	-12.2%	438,033	-11.7%
Individual Equity Products	1,483	1,319	12.5%	32,636	29,021	12.5%	1,675	-14.5%	323,229	-14.0%
Futures	967	703	37.4%	21,266	15,475	37.4%	1,063	-16.0%	205,169	-15.6%
Options	517	616	-16.1%	11,369	13,545	-16.1%	612	-11.7%	118,060	-11.3%
Equity Index Products	687	612	12.2%	15,124	13,474	12.2%	595	-4.8%	114,805	-4.3%
of which Bclear	1,179	893	32.0%	25,941	19,648	32.0%	1,232	-16.7%	237,718	-16.3%
Individual Equity Products	1,065	792	34.5%	23,431	17,427	34.5%	1,150	-16.7%	221,876	-16.3%
Futures	962	701	37.1%	21,154	15,432	37.1%	1,045	-17.1%	201,767	-16.7%
Options	104	91	14.2%	2,277	1,995	14.2%	104	-12.9%	20,109	-12.5%
Equity Index Products	114	101	12.9%	2,509	2,222	12.9%	82	-16.8%	15,841	-16.4%
Commodity Products	91	77	18.8%	2,010	1,692	18.8%	84	32.3%	16,131	33.0%
U.S. Derivatives Products
Equity Options^3
NYSE Euronext Options Contracts	4,588	3,473	32.1%	96,351	72,928	32.1%	4,445	21.6%	840,169	22.2%
Total Consolidated Options Contracts	17,134	13,319	28.6%	359,818	279,696	28.6%	17,187	22.3%	3,248,325	22.9%
NYSE Group Share of Total	26.8%	26.1%		26.8%	26.1%		25.9%	-0.1%	25.9%	-0.1%
NYSE Liffe U.S.
Futures and Futures Options Volume*	113.4	10.8	947.2%	2,495	227	997.1%	77.8	368.6%	15,100.6	383.6%
European Cash Products (trades in thousands)	1,882	1,399	34.6%	41,402	30,770	34.6%	1,753	18.2%	338,267	18.8%
Equities	1,804	1,341	34.5%	39,684	29,508	34.5%	1,684	18.3%	325,084	18.9%
Exchange-Traded Funds	26	17	56.1%	576	369	56.1%	21	15.6%	3,988	16.2%
Structured Products	47	35	34.7%	1,037	770	34.7%	43	19.5%	8,223	20.1%
Bonds	5	6	-14.4%	106	124	-14.4%	5	-12.7%	972	-12.3%
U.S. Cash Products (shares in millions)^5	2,558	2,278	12.3%	53,709	47,829	12.3%	2,333	-14.2%	440,850	-13.8%
NYSE Listed (Tape A) Issues ^4
Handled Volume ^5	1,761	1,625	8.3%	36,976	34,134	8.3%	1,646	-16.5%	311,061	-16.1%
Matched Volume ^6	1,678	1,547	8.5%	35,241	32,477	8.5%	1,560	-15.5%	294,921	-15.1%
Total NYSE Listed Consolidated Volume	4,622	4,026	14.8%	97,054	84,545	14.8%	4,436	-12.2%	838,416	-11.7%
Share of Total Consolidated Volume
Handled Volume ^5	38.1%	40.4%	-2.3%	38.1%	40.4%	-2.3%	37.1%	-1.9%	37.1%	-1.9%
Matched Volume ^6	36.3%	38.4%	-2.1%	36.3%	38.4%	-2.1%	35.2%	-1.4%	35.2%	-1.4%
NYSE Arca & Amex (Tape B) Listed Issues
Handled Volume ^5	477	339	40.9%	10,025	7,118	40.9%	384	-5.3%	72,582	-4.8%
Matched Volume ^6	432	311	39.1%	9,074	6,525	39.1%	346	-5.0%	65,340	-4.5%
Total NYSE Arca & Amex Listed Consolidated Volume	1,806	1,229	46.9%	37,916	25,812	46.9%	1,481	-3.4%	279,949	-2.9%
Share of Total Consolidated Volume
Handled Volume ^5	26.4%	27.6%	-1.2%	26.4%	27.6%	-1.2%	25.9%	-0.5%	25.9%	-0.5%
Matched Volume ^6	23.9%	25.3%	-1.4%	23.9%	25.3%	-1.4%	23.3%	-0.4%	23.3%	-0.4%
Nasdaq Listed (Tape C) Issues
Handled Volume ^5	319	313	2.0%	6,708	6,577	2.0%	303	-11.4%	57,208	-10.9%
Matched Volume ^6	282	272	3.7%	5,928	5,714	3.7%	260	-9.4%	49,214	-8.9%
Total Nasdaq Listed Consolidated Volume	2,089	2,021	3.4%	43,874	42,447	3.4%	2,077	-9.5%	392,592	-9.0%
Share of Total Consolidated Volume
Handled Volume ^5	15.3%	15.5%	-0.2%	15.3%	15.5%	-0.2%	14.6%	-0.3%	14.6%	-0.3%
Matched Volume ^6	13.5%	13.5%	0.0%	13.5%	13.5%	0.0%	12.5%	0.0%	12.5%	0.0%
Exchange-Traded Funds ^5,7
Handled Volume ^5	465	329	41.5%	9,769	6,906	41.5%	360	-7.9%	68,122	-7.5%
Matched Volume ^6	421	301	39.7%	8,832	6,322	39.7%	324	-7.9%	61,281	-7.4%
Total ETF Consolidated Volume	1,797	1,214	48.0%	37,737	25,501	48.0%	1,416	-6.7%	267,573	-6.2%
Share of Total Consolidated Volume
Handled Volume ^5	25.9%	27.1%	-1.2%	25.9%	27.1%	-1.2%	25.5%	-0.3%	25.5%	-0.3%
Matched Volume ^6	23.4%	24.8%	-1.4%	23.4%	24.8%	-1.4%	22.9%	-0.3%	22.9%	-0.3%

^1	Data includes currency products.
^2	Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.
^3	Includes trading in U.S. equity options contracts, not equity-index options.
^4	Includes all volume executed in NYSE Group crossing sessions.
^5	Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
^6	Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
^7	Data included in previously identified categories.
^*	ADVs calculated with the appropriate number of NYSE Liffe U.S. trading.
	Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
	All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.